NIH and NASA Partner on QuSAFE Challenge

NIH and NASA are collaborating on the QuSAFE Challenge. The effort advances quantum-enabled sensing for in vitro NAMs to improve drug safety and reduce animal use.

In vitro NAMs produce human-relevant data used in drug development and safety evaluation.

Conventional assays and imaging can be noisy, invasive, and not sensitive enough.

Faint, early, and scarce biological signals may go undetected, while destructive measurements make dynamic monitoring difficult.

Quantum-enabled sensing approaches provide ultra-high sensitivity, improved signal-to-noise performance, and nanoscale resolution to overcome detection and measurement limits.

The challenge supports NASA's Biological and Physical Sciences Division and seeks advanced detection methods usable outside traditional laboratories.

It enhances NASA's space exploration capabilities and benefits science in space and on Earth.

Two dates associated with the challenge are 2026-12-15 and 2027-07-27.

A website for the challenge is https://www.qusafechallenge.com/.

For readers tracking the lunar industry, the NASA connection matters because the challenge is tied to space exploration capabilities and science in space. Its focus on detection methods outside traditional labs is also relevant to work beyond conventional research settings.